Platelet-to-lymphocyte ratio and the first occurrence of peritonitis in peritoneal dialysis patients

BMC Nephrol. 2022 Dec 30;23(1):415. doi: 10.1186/s12882-022-03038-5.

Abstract

Background: Platelet-to-lymphocyte ratio (PLR) has been used as a potential biomarker of inflammation-related diseases, but its role in the peritoneal dialysis-related peritonitis (PDRP) is still uncertain. This study was aimed to investigate the association between PLR and the new-onset PDRP in peritoneal dialysis (PD) patients.

Methods: In this multicenter retrospective study, 1378 PD Chinese PD patients were recruited from four centers, who were divided into the high PLR group (HPG) and the low PLR group (LPG) according to the cutoff value of PLR. The correlation between PLR and the new-onset PDRP was assessed using the Cox regression model analysis.

Results: During follow-up, 121 new-onset PDRP events were recorded. Kaplan-Meier survival curve showed a higher risk of new-onset PDRP in the HPG (log-rank test, P < 0.001). After adjusting for confounding factors, the Cox regression model showed the risk of new-onset PDRP was higher in the HPG than that in the LPG (HR 1.689, 95%CI 1.096-2.602, P = 0.017). Competitive risk model analysis showed that significant differences still existed between the two PLR groups in the presence of other competitive events (P < 0.001).

Conclusion: PLR is independently associated with the new-onset PDRP in PD patients.

Keywords: Peritoneal dialysis; Peritonitis; Platelet-to-lymphocyte ratio.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Blood Platelets
  • Humans
  • Lymphocytes
  • Neutrophils
  • Peritoneal Dialysis* / adverse effects
  • Peritonitis* / epidemiology
  • Peritonitis* / etiology
  • Prognosis
  • Retrospective Studies